Stephens lowered the firm’s price target on Bunge (BG) to $85 from $90 and keeps an Overweight rating on the shares after the company reported Q1 results. Near-term results are expected to remain challenged, but with the potential for a significant increase in the 2026 BBD RVO, board crush margins are seen being “healthy” in the back half of FY25, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG: